CGON - CG Oncology, Inc.

QQQ $ 634.25 $ 0.00 (0 %)

DIA $ 475.56 $ 0.00 (0 %)

SPY $ 685.29 $ 0.00 (0 %)

TLT $ 90.32 $ 0.00 (0 %)

GLD $ 368.20 $ 0.00 (0 %)

Previous Close

$ 42.47

Open

$ 43.20

Bid

$ 41.19 x 1

Ask

$ 45.17 x 1

Day's Range

-- - --

52 Week Range

$ 14.80 - $ 45.56

Volume

806,535

Average Volume

Market Cap

Beta (5Y Monthly)

$ 2.14

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na (nm)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-28-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-26-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Initiates Coverage On CG Oncolo...
10/08/2025 12:47:27

Guggenheim analyst Brad Canino initiates coverage on CG Oncology (NASDAQ:CGON) with a Buy rating and announces Price Target ...

JP Morgan Maintains Overweight on CG Oncol...
09/26/2025 11:46:45

JP Morgan analyst Brian Cheng maintains CG Oncology (NASDAQ: CGON) with a Overweight and raises the price target from $41 to...

Morgan Stanley Maintains Overweight on CG ...
09/17/2025 18:00:33

Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $...

HC Wainwright & Co. Reiterates Buy on CG O...
09/15/2025 11:48:36

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price ...

Jones Trading Initiates Coverage On CG Onc...
09/08/2025 16:26:02

Jones Trading analyst Soumit Roy initiates coverage on CG Oncology (NASDAQ:CGON) with a Buy rating and announces Price Targe...

Cantor Fitzgerald Reiterates Overweight on...
09/08/2025 13:31:45

Cantor Fitzgerald analyst Josh Schimmer reiterates CG Oncology (NASDAQ:CGON) with a Overweight and maintains $75 price target.

cg-oncology-stock-signals-bullish-momentum-ahead

CG Oncology Stock Signals Bullish Momentum...
09/08/2025 13:08:27

CG Oncology has entered its Phase 2 of the Adhishthana Cycle, signaling a bullish setup. With momentum already building, here&#...

HC Wainwright & Co. Reiterates Buy on CG O...
09/08/2025 11:55:24

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price ...

HC Wainwright & Co. Reiterates Buy on CG O...
09/05/2025 18:30:13

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price ...

CG Oncology Announced Updated Data On BOND...
09/05/2025 11:04:31

Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-mus...

CG Oncology Completes Enrollment In Pivota...
09/03/2025 12:14:18

– Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) –– One of the la...

CG Oncology Q2 EPS $(0.54) Misses $(0.48) ...
08/08/2025 13:43:02

CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.48)...

Delaware Court Gives Unanimous Verdict Det...
07/29/2025 20:24:44

CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a po...

12 Health Care Stocks Moving In Tuesday's ...
07/22/2025 12:07:15

Beyond The Numbers: 7 Analysts Discuss CG ...
07/16/2025 21:03:09

RBC Capital Maintains Outperform on CG Onc...
07/16/2025 15:32:34

RBC Capital analyst Leonid Timashev maintains CG Oncology (NASDAQ:CGON) with a Outperform and lowers the price target from $...

CG Oncology Corleen Roche Resigns As CFO, ...
07/11/2025 20:19:20

-SEC Filing

Morgan Stanley Maintains Overweight on CG ...
06/17/2025 15:02:51

Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $...

Morgan Stanley Maintains Overweight on CG ...
05/19/2025 14:33:57

Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:CGON) with a Overweight and lowers the price target from $...

CG Oncology Q1 EPS $(0.45) Misses $(0.41) ...
05/13/2025 12:06:21

CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.41)...